Results 121 to 130 of about 7,326 (212)

PKM2 Promotes Glycolysis in Alveolar Macrophages and Induces Inflammation in Bronchopulmonary Dysplasia. [PDF]

Inflammation
Mo X, Yao H, Ju H, Wang M, Yi M, Lu Y, Zhu Y, Lu H.   +7 more
europepmc   +1 more source

Shikonin improves intestinal barrier function through modulation of GPX4 expression in intestinal epithelial cells. [PDF]

Int J Immunopathol Pharmacol
Yang F, Liang P, Guo H, Yan W, Wang G, Tang X, Liang Z.   +6 more
europepmc   +1 more source

Metabolic Engineering [PDF]

, 2001
中村 憲夫, 宮代 博継, 服部 征雄, 横澤 隆子   +3 more
core   +2 more sources

Antibacterial potential of danthron, embelin, sanguinarine and shikonin against multidrug-resistant Neisseria gonorrhoeae in vitro. [PDF]

Int Microbiol
Qi Y, Zhang R, Peng H, Tao C, Tang Y, Lu S, Ke Q, Shen S, Wang Z, Lin X.   +9 more
europepmc   +1 more source

Expression of Concern: Shikonin Kills Glioma Cells through Necroptosis Mediated by RIP-1. [PDF]

PLoS One
PLOS One Editors.
europepmc   +1 more source

Shikonin inhibits MRSA biofilm formation to alleviate periprosthetic joint infection. [PDF]

Front Pharmacol
Liu S, Zhang H, Zheng X, Mou X, Wu Z, Zou L, Shou K, Liu X.   +7 more
europepmc   +1 more source

Shikonin alleviates rotenone-induced Parkinson's disease neuroinflammation by targeting PKM2-mediated glycolytic MG-Hs production. [PDF]

Cell Commun Signal
Zhao Y, Wang D, Mu D, Qu L, Li R.
europepmc   +1 more source

Correction: Guo et al. Shikonin as a WT1 Inhibitor Promotes Promyeloid Leukemia Cell Differentiation. <i>Molecules</i> 2022, <i>27</i>, 8264. [PDF]

Molecules
Guo Z, Sun L, Xia H, Tian S, Liu M, Hou J, Li J, Lin H, Du G.   +8 more
europepmc   +1 more source

Potential Regulatory Role of miR-15b, miR-99b, and miR-181a of the Shikonin-Induced MAPK/ERK Apoptotic Signaling Pathway in Renal Carcinoma. [PDF]

Biomedicines
Vass A, Király J, Szabó E, Shree N, Ramos D, Choudhury M, Fodor P, Szegedi K, Halmos G, Szabó Z.   +9 more
europepmc   +1 more source

Development and validation of a UPLC-MS/MS method for the quantification of asciminib and its pharmacokinetic interaction and metabolic stability with shikonin. [PDF]

BMC Pharmacol Toxicol
Zhou C, Xia H, Hu Y, Chen X, Zou Q, Xu X, Jiang ZL.   +6 more
europepmc   +1 more source